Acute myeloid leukaemia aggravated and Gastrointestinal inflammation

Summary:

Gastrointestinal inflammation is found among people with Acute myeloid leukaemia aggravated, especially for people who are female, 50-59 old.

The study analyzes which people have Gastrointestinal inflammation with Acute myeloid leukaemia aggravated. It is created by eHealthMe based on reports of 28 people who have Acute myeloid leukaemia aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 21, 2022

28 people who have Acute Myeloid Leukaemia Aggravated and Gastrointestinal Inflammation are studied.


What is Acute myeloid leukaemia aggravated?

Acute myeloid leukaemia aggravated (serious acute cancer in which the bone marrow makes abnormal myeloblasts) is found to be associated with 530 drugs and 257 conditions by eHealthMe.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 759 drugs and 492 conditions by eHealthMe.

Number of Gastrointestinal inflammation in Acute myeloid leukaemia aggravated reports submitted per year:

Would you have Gastrointestinal inflammation when you have Acute myeloid leukaemia aggravated?

Gender of people who have Acute Myeloid Leukaemia Aggravated and experienced Gastrointestinal Inflammation *:

  • female: 51.85 %
  • male: 48.15 %

Age of people who have Acute Myeloid Leukaemia Aggravated and experienced Gastrointestinal Inflammation *:

  • 0-1: 0.0 %
  • 2-9: 3.85 %
  • 10-19: 11.54 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.85 %
  • 50-59: 42.31 %
  • 60+: 38.46 %

Common co-existing conditions for these people *:

  1. Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 3 people, 10.71%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 7.14%
  3. Neoplasm Recurrence (reoccurrence of tumour): 1 person, 3.57%
  4. Melaena (the passage of black, tarry stools): 1 person, 3.57%

Common drugs taken by these people *:

  1. Etoposide: 8 people, 28.57%
  2. Zovirax: 3 people, 10.71%
  3. Posaconazole: 3 people, 10.71%
  4. Cytarabine: 3 people, 10.71%
  5. Torisel: 2 people, 7.14%
  6. Clofarabine: 2 people, 7.14%
  7. Vitamin D: 1 person, 3.57%
  8. Vancomycin: 1 person, 3.57%
  9. Temsirolimus: 1 person, 3.57%
  10. Phytonadione: 1 person, 3.57%

Common symptoms for these people *:

  1. Diarrhea: 11 people, 39.29%
  2. Abdominal Pain: 5 people, 17.86%
  3. Stomatitis Necrotising (inflammation of mucous membrane of mouth with cell damage): 4 people, 14.29%
  4. Pleural Effusion (water on the lungs): 4 people, 14.29%
  5. Rashes (redness): 4 people, 14.29%
  6. Geotrichum Infection (fungal infection by geotrichum): 4 people, 14.29%
  7. Nausea And Vomiting: 4 people, 14.29%
  8. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 14.29%
  9. Hyperpyrexia (extremely high fever): 3 people, 10.71%
  10. Neoplasm Progression (growth of tumour): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Gastrointestinal inflammation:

Common drugs associated with Gastrointestinal inflammation:

All the drugs that are associated with Gastrointestinal inflammation:

Common conditions associated with Gastrointestinal inflammation:

All the conditions that are associated with Gastrointestinal inflammation:

How the study uses the data?

The study is based on Gastrointestinal inflammation and Acute myeloid leukaemia aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: